Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Dinalbuphine Sebacate in Postoperative Pain Control After TKA [Phase 4]

View source ↗

Summary

Phase 4 trial update of Dinalbuphine Sebacate for postoperative pain control after total knee arthroplasty in knee osteoarthritis; the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dinalbuphine sebacate (dinalbuphine sebacate)

Snippet

Sponsor: Thammasat University | Conditions: Osteo Arthritis of the Knee, Total Knee Anthroplasty | Phase 4 | Status: NOT_YET_RECRUITING